Table 1.
Baseline patient characteristics.
| Variables | |
|---|---|
| Age (median, range) | 76, (30–88) years |
| Sex n, (%) | |
| Male | 38, (71.7%) |
| Female | 15, (28.3%) |
| BCLC stage n, (%) | |
| 0 | 3, (5.7%) |
| A | 18, (34%) |
| B | 17, (32.1%) |
| C | 12, (22.6%) |
| D | 3, (5.7%) |
| Liver disease n, (%) | |
| HCV infection | 28, (52.8%) |
| HBV infection | 17, (32.1%) |
| NASH | 4, (7.5%) |
| Alcoholic liver disease | 2, (3.8%) |
| Other | 2, (3.8%) |
| Child–Pugh score n, (%) | |
| A | 33, (62.3%) |
| B | 19, (35.8%) |
| C | 1, (1.9%) |
| Tumor size n, (%) | |
| >5 cm | 40, (75.4%) |
| ≤5 cm | 13, (24.5%) |
| Number of lesions n, (%) | |
| Single | 16, (30.2%) |
| Multiple | 37, (69.8%) |
| Patients submitted to TACE | 33, (62.3%) |
| BCLC A | 12, (36.4%) |
| BCLC B | 15, (45.5%) |
| BCLC C | 6, (18.1%) |
HCV: hepatitis C virus; HBV: hepatitis B virus; NASH: non-alcoholic steatohepatitis; TACE: transarterial chemoembolization; BCLC: Barcelona Clinic Liver Cancer.